C. Berkman

发表

N‐Substituted Glutamyl Sulfonamides as Inhibitors of Glutamate Carboxypeptidase II (GCP2)

Brian R. Blank, Marc O. Anderson, W. Engen, 2011, Chemical biology & drug design.

Synthesis, absolute configuration, and analysis of malathion, malaoxon, and isomalathion enantiomers.

C. Thompson, C. Berkman, S. Perrin, 1993, Chemical research in toxicology.

Inhibition of Various Cholinesterases with the Enantiomers of Malaoxon

C. Thompson, C. M. Thompson, C. Berkman, 1997, Bulletin of environmental contamination and toxicology.

InVitroTargeted PhotodynamicTherapyWith a Pyropheophorbide-aConjugated Inhibitorof Prostate-SpecificMembraneAntigen

Joseph K. Choi, C. Berkman, Lisa Y. Wu, 2009 .

Cocaine benzoyl thioester: synthesis, kinetics of base hydrolysis, and application to the assay of cocaine esterases.

J. Cashman, A. D. Hunter, C. Kolly, 1998, Chemical research in toxicology.

Substrate specificity of prostate-specific membrane antigen.

Marc O. Anderson, C. Berkman, Lisa Y. Wu, 2007, Bioorganic & medicinal chemistry.

Probing for a hydrophobic a binding register in prostate-specific membrane antigen with phenylalkylphosphonamidates.

C. Berkman, T. Girtsman, Lisa Y. Wu, 2004, Bioorganic & medicinal chemistry.

N-oxygenation of primary amines and hydroxylamines and retroreduction of hydroxylamines by adult human liver microsomes and adult human flavin-containing monooxygenase 3.

J. Cashman, C. Berkman, J. Lin, 1996, Chemical research in toxicology.

Capture and visualization of hydrogen sulfide by a fluorescent probe.

Yu Zhao, M. Xian, Sheng Li, 2011, Angewandte Chemie.

Kinetic evidence for different mechanisms of acetylcholinesterase inhibition by (1R)- and (1S)-stereoisomers of isomalathion.

C. Thompson, T. Talley, R. Richardson, 1999, Toxicology and applied pharmacology.

Relative potencies of the four stereoisomers of isomalathion for inhibition of hen brain acetylcholinesterase and neurotoxic esterase in vitro.

C. Thompson, R. Richardson, S. Jianmongkol, 1996, Toxicology and applied pharmacology.

Review: Isolation and Detection of Tumor-Derived Extracellular Vesicles

M. G. Norton, C. Berkman, P. Ziaei, 2018 .

Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.

Tiancheng Liu, Benjamin B. Kasten, Paul D Benny, 2013, Bioorganic & medicinal chemistry letters.

Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen.

Tiancheng Liu, C. Berkman, Jessie R. Nedrow-Byers, 2011, Bioorganic & medicinal chemistry letters.

Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure.

J. Cashman, C. Berkman, G. Underiner, 2000, The Journal of pharmacology and experimental therapeutics.

Structure–Activity Relationship of 18F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer

H. VanBrocklin, Christopher R. Drake, E. Jones, 2018 .

Phosphoramidate derivates as controlled-release prodrugs of l-Dopa.

C. Berkman, C. J. Choy, F. Olatunji, 2019, Bioorganic & medicinal chemistry letters.

Synthesis of N‐Thiophosphoryl Amino Acids via Phosphoramidite Amine‐Exchange

C. Shieh, C. Berkman, Jack Maung, 2004 .

Stereoselective inhibition of glutamate carboxypeptidase by organophosphorus derivatives of glutamic acid.

Ying Hu, S. Pavkovic, C. Berkman, 2004, Bioorganic & medicinal chemistry.

Inhibition of Glutamate Carboxypeptidase by Phosphoryl and Thiophosphoryl Derivatives of Glutamic and 2-Hydroxyglutaric Acid

C. Shieh, C. Berkman, Haiyan Lu, 2003 .

Stereoselective inhibition of glutamate carboxypeptidase by chiral phosphonothioic acids.

C. Berkman, H. Lu, H. Lu, 2001, Bioorganic & medicinal chemistry.

Synthesis of individual glutamate-containing phosphonamidothionate stereoisomers

Ying Hu, C. Berkman, J. Mallari, 2001 .

Competitive inhibition of a glutamate carboxypeptidase by phosphonamidothionate derivatives of glutamic acid.

C. Berkman, V. Lam, H. Lu, 1999, Bioorganic & medicinal chemistry letters.

A general high-performance liquid chromatography-based assay for the hydrolysis of N-acyl glutamates.

C. Berkman, R. Myers, J. R. Martell, 1999, Analytical biochemistry.

Synthesis of N-phosphoryl amino acids via phosphoramidite amine-exchange

C. Berkman, Chun P. Chow, 1998 .

Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen.

Marc O. Anderson, Marat Kazak, C. Berkman, 2008, Bioorganic & medicinal chemistry letters.

Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption.

Tiancheng Liu, C. Berkman, Lisa Y. Wu, 2010, Cancer letters.

A click-ready pH-triggered phosphoramidate-based linker for controlled release of monomethyl auristatin E.

C. Berkman, F. Olatunji, Brittany N. Kesic, 2020, Tetrahedron letters.

Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities

J. Lubkowski, J. Černý, C. Bařinka, 2016, The FEBS journal.

Tunable pH-Sensitive 2-Carboxybenzyl Phosphoramidate Cleavable Linkers.

Brian S. Backer, C. Berkman, C. J. Choy, 2020, Tetrahedron letters.

Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium.

J. Bryan, Tiancheng Liu, C. Berkman, 2011, International journal of oncology.

Pseudoirreversible inhibition of prostate-specific membrane antigen by phosphoramidate peptidomimetics.

Tiancheng Liu, Marat Kazak, C. Berkman, 2008, Biochemistry.

Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403

C. Laymon, B. Kurland, L. Rigatti, 2019, Molecular Imaging and Biology.

177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice

C. Anderson, C. Berkman, Joseph D Latoche, 2017, Theranostics.

Phosphorus containing analogues of SAHA as inhibitors of HDACs

J. W. Peters, C. Berkman, Hsin-Hua Wu, 2022, Journal of enzyme inhibition and medicinal chemistry.

Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer

B. Kurland, C. Anderson, D. Zeng, 2015, Molecular Imaging and Biology.

Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer

Kirsten L. Greene, M. Cooperberg, P. Carroll, 2018, The Journal of Nuclear Medicine.

First-in-Human Phase I study of CTT1057, a Novel 18F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate Cancer

M. Cooperberg, P. Carroll, J. Kurhanewicz, 2018 .

Stereoselective inhibition of human butyrylcholinesterase by phosphonothiolate analogs of (+)- and (-)-cocaine.

J. Cashman, C. Berkman, G. Underiner, 1997, Biochemical pharmacology.

The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen.

Cheryl A. Tajon, Marc O. Anderson, Marat Kazak, 2007, Bioorganic & medicinal chemistry.

Purification of prostate-specific membrane antigen using conformational epitope-specific antibody-affinity chromatography.

Tiancheng Liu, C. Berkman, Yoko Toriyabe, 2006, Protein expression and purification.

Chemoenzymatic resolution of rac-malathion.

J. Suhy, C. Thompson, C. Berkman, 2014, Tetrahedron, asymmetry.

Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans.

J. Cashman, C. Berkman, S. B. Park, 1995, Chemico-biological interactions.

Inhibition of IGF-1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogs.

J. Youngren, Marc O. Anderson, C. Berkman, 2007, Bioorganic & medicinal chemistry letters.

Synthesis of chiral malathion and isomalathion

C. Thompson, C. Berkman, 1992 .

Dimethyl (E)‐4‐Oxo‐2‐pentenedioate

C. Berkman, 2001 .

Stereoselective and chemoselective oxidation of phosphorothionates using MMPP

C. Thompson, C. Berkman, J. A. Jackson, 1992 .

Kinetics of the postinhibitory reactions of acetylcholinesterase poisoned by chiral isomalathion: a surprising nonreactivation induced by the RP stereoisomers.

C. Thompson, C. Berkman, D. Quinn, 1993, Chemical research in toxicology.

Inhibition of Glutamate Carboxypeptidase II by Phosphonamidothionate Derivatives of Glutamic Acid

Y. Hu, C. Berkman, A. Brunelle, 2001, Journal of enzyme inhibition.

Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate Cancer

H. VanBrocklin, E. Jones, Tiancheng Liu, 2009, Journal of Nuclear Medicine.

A simple method for the oxidation of α-amino acid esters to α-oximino esters

Joseph K. Choi, C. Berkman, Lisa Y. Wu, 2010 .

Pharmacokinetics and molecular detoxication.

J R Cashman, J. Cashman, C. Berkman, 1996, Environmental health perspectives.

Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer

M. Black, G. Munske, C. Berkman, 2014, Bioconjugate chemistry.

Synthesis of Malathion, Malaoxon, and Isomalathion Enantiomers and Examination of Their Interactions with Acetylcholinesterase

C. Berkman, 1994 .

Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled Release.

Brian S. Backer, B. Clowers, C. Berkman, 2016, Bioconjugate chemistry.

Tunable pH-Sensitive Linker for Controlled Release.

C. Berkman, Jonathan J. Geruntho, C. J. Choy, 2016, Bioconjugate chemistry.

Crystal Structure of Phosphoserine BlaC from Mycobacterium tuberculosis Inactivated by Bis(Benzoyl) Phosphate

C. Kang, C. Berkman, D. White, 2019, International journal of molecular sciences.

Prolonged androgen deprivation leads to overexpression of calpain 2: Implications for prostate cancer progression

Tiancheng Liu, C. Berkman, D. Mendes, 2013, International journal of oncology.

From AR to c-Met: Androgen deprivation leads to a signaling pathway switch in prostate cancer cells

Tiancheng Liu, C. Berkman, D. Mendes, 2013, International journal of oncology.

Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells

Tiancheng Liu, C. Berkman, Lisa Y. Wu, 2012, International journal of oncology.

Interaction of acetylcholinesterase with the enantiomers of malaoxon and isomalathion.

C. Thompson, C. Berkman, D. Quinn, 1993, Chemical research in toxicology.

Silica nanostructured platform for affinity capture of tumor-derived exosomes

Oscar G. Marin-Flores, C. Berkman, M. Grant Norton, 2017, Journal of Materials Science.

Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells

Tiancheng Liu, C. Berkman, D. Mendes, 2014, International journal of oncology.

Consequence of phosphorus stereochemistry upon the postinhibitory reaction kinetics of acetylcholinesterase poisoned by phosphorothiolates

C. Thompson, C. Berkman, S. Ryu, 1992 .

Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs.

J. Cashman, W. Bosron, C. Berkman, 1997, Drug metabolism and disposition: the biological fate of chemicals.

Characterization of two human flavin-containing monooxygenase (form 3) enzymes expressed in Escherichia coli as maltose binding protein fusions.

J. Cashman, B. Russell, Y. Bi, 1997, Drug metabolism and disposition: the biological fate of chemicals.

In vitro-in vivo correlations of human (S)-nicotine metabolism.

S. Wrighton, J. Cashman, C. Berkman, 1995, Biochemical pharmacology.

Rationally Designed Sulfamides as Glutamate Carboxypeptidase II Inhibitors

Marc O. Anderson, Joseph K. Choi, C. Berkman, 2013, Chemical biology & drug design.

177 Lu-Labeled Phosphoramidate-Based PSMA Inhibitors : The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice

C. Anderson, C. Berkman, Joseph D Latoche, 2017 .

Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer.

H. VanBrocklin, Christopher R. Drake, E. Jones, 2016, Journal of medicinal chemistry.

PSMA‐targeted SPECT agents: Mode of binding effect on in vitro performance

Paul D Benny, C. Berkman, Jessie R. Nedrow-Byers, 2013, The Prostate.

A phosphoramidate‐based prostate‐specific membrane antigen‐targeted SPECT agent

J. Bryan, Tiancheng Liu, Paul D Benny, 2012, The Prostate.

A targeted low molecular weight near-infrared fluorescent probe for prostate cancer.

Tiancheng Liu, Tiancheng Liu, Lisa Y Wu, 2010, Bioorganic & medicinal chemistry letters.

Cell‐Surface labeling and internalization by a fluorescent inhibitor of prostate‐specific membrane antigen

Tiancheng Liu, Marat Kazak, C. Berkman, 2008, The Prostate.

Expression of prostate‐specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non‐polyglutamated folate, folic acid

D. O’Keefe, D. Bacich, V. Yao, 2010, The Prostate.

The Prostate 68 : 955 ^ 964 ( 2008 ) Cell-Surface Labeling and Internalizationbya Fluorescent Inhibitorof Prostate-Specific MembraneAntigen

Tiancheng Liu, Marat Kazak, C. Berkman, 2008 .

High resolution time-of-flight mass analysis of the entire range of intact singly-charged proteins.

Jeonghoon Lee, Tiancheng Liu, P. Reilly, 2011, Analytical chemistry.

Inhibition of acetylcholinesterases by stereoisomeric organophosphorus compounds containing both thioester and p-nitrophenyl leaving groups.

C. Thompson, T. Talley, R. Richardson, 2020, Chemical research in toxicology.

The pathway for coenzyme M biosynthesis in bacteria

J. W. Peters, B. M. Lange, D. Gang, 2022, Proceedings of the National Academy of Sciences of the United States of America.

A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.

H. VanBrocklin, Christopher R. Drake, E. Jones, 2015, Nuclear medicine and biology.

The hydrazide/hydrazone click reaction as a biomolecule labeling strategy for M(CO)3 (M = Re, (99m)Tc) radiopharmaceuticals.

L. MacGillivray, Benjamin B. Kasten, Dejan-Krešimir Bučar, 2011, Chemical communications.

Targeted photodynamic therapy for prostate cancer: inducing apoptosis via activation of the caspase-8/-3 cascade pathway.

Tiancheng Liu, Tiancheng Liu, Lisa Y Wu, 2010, International journal of oncology.

In vitro targeted photodynamic therapy with a pyropheophorbide‐a conjugated inhibitor of prostate‐specific membrane antigen

Tiancheng Liu, Joseph K. Choi, C. Berkman, 2009, The Prostate.

Synthesis of N-phosphoryl amino acids using bis(9-fluorenylmethyl)phosphite

C. Berkman, Lisa Y. Wu, 2005 .

D. O’Keefe, D. Bacich, V. Yao, 2010, The Prostate.

SYNTHESIS OF AN IMMUNOGENIC TEMPLATE FOR THE GENERATION OF CATALYTIC ANTIBODIES FOR (-)-COCAINE HYDROLYSIS

J. Cashman, C. Berkman, G. Underiner, 1996 .

Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate.

Jeonghoon Lee, Tiancheng Liu, P. Reilly, 2012, Bioorganic & medicinal chemistry letters.

Flow cytometric detection of prostate tumor cells using chemoaffinity labels

W. Davis, Tiancheng Liu, C. Berkman, 2011, The Prostate.

High-performance liquid chromatography method for detecting prostate-specific membrane antigen activity.

C. Berkman, M. Hosaka, Rudy Ng, 2002, Analytical biochemistry.

Modular Smart Molecules for PSMA-Targeted Chemotherapy.

C. Anderson, J. Beumer, C. Berkman, 2022, Molecular cancer therapeutics.

First-in-human phase 1 PET study of CTT1057, a novel 18F-labeled imaging agent targeting prostate specific membrane antigen (PSMA) in prostate cancer.

S. Behr, Youngho Seo, H. VanBrocklin, 2017 .

Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase

C. Berkman, A. Wong-On-Wing, Desiree E. Mendes, 2016, Journal of enzyme inhibition and medicinal chemistry.

Chemoaffinity capture of pre‐targeted prostate cancer cells with magnetic beads

W. Davis, Tiancheng Liu, C. Berkman, 2012, The Prostate.

Optimizing phenylethylphosphonamidates for the inhibition of prostate-specific membrane antigen.

C. Berkman, Jennifer A Rowley, A. W. Garofalo, 2006, Bioorganic & medicinal chemistry.

Pseudoirreversible inhibition of prostate-specific membrane antigen by phosphoramidate peptidomimetics.

Tiancheng Liu, Marat Kazak, C. Berkman, 2008, Biochemistry.

Prostate-Specific Membrane Antigen-Targeted Turn-on Probe for Imaging Cargo Release in Prostate Cancer Cells.

L. Caromile, C. Berkman, F. Olatunji, 2021, Bioconjugate chemistry.

A method to determine the mode of binding for GCPII inhibitors using bio-layer interferometry

C. Berkman, C. J. Choy, 2016, Journal of Enzyme Inhibition and Medicinal Chemistry.

Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen.

H. VanBrocklin, S. Dannoon, C. Berkman, 2015, Bioorganic & medicinal chemistry letters.

Biochemical characterization of prostate‐specific membrane antigen from canine prostate carcinoma cells

T. Rosol, W. P. Dirksen, W. Davis, 2014, The Prostate.

Bis(benzoyl) phosphate inactivators of beta-lactamase C from Mtb.

C. Kang, C. Berkman, D. White, 2019, Bioorganic & medicinal chemistry letters.

A modular template for the design of thiol-triggered sensors and prodrugs.

M. Xian, C. Berkman, Shi Xu, 2020, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled Release.

Brian S. Backer, B. Clowers, C. Berkman, 2016, Bioconjugate chemistry.

Synthesis of N-Phosphonamidothionate Derivatives of Glutamic Acid

C. Berkman, V. Lam, Haiyan Lu, 1999 .